K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Eric Van Cutsem
also known as Cutsem, Eric Van, E Van Cutsem, E van Cutsem
Universitair Ziekenhuis Leuven · KU Leuven · Université Claude Bernard Lyon 1 · AstraZeneca (United Kingdom)
About this author
Works
1,826
Cited by
174,645
h-index
176
i10
845
ORCID ↗
Top papers
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova, et al.
·
2010
·
The Lancet
↗ 7,232
OA
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena, et al.
·
2013
·
New England Journal of Medicine
↗ 6,587
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
David Cunningham, Yves Humblet, Salvatore Siena, et al.
·
2004
·
New England Journal of Medicine
↗ 5,044
OA
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre, et al.
·
2009
·
New England Journal of Medicine
↗ 3,851
OA
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Eric Van Cutsem, Andrés Cervantes, René Adam, et al.
·
2016
·
Annals of Oncology
↗ 3,416
OA
Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Rafael G. Amado, Michael Wolf, Marc Peeters, et al.
·
2008
·
Journal of Clinical Oncology
↗ 3,147
OA
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin, et al.
·
2017
·
New England Journal of Medicine
↗ 3,100
OA
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
Thierry André, Kai‐Keen Shiu, Tae Won Kim, et al.
·
2020
·
New England Journal of Medicine
↗ 2,879
OA
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Axel Grothey, Eric Van Cutsem, Alberto Sobrero, et al.
·
2012
·
The Lancet
↗ 2,874
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
James C. Yao, Manisha H. Shah, Tetsuhide Ito, et al.
·
2011
·
New England Journal of Medicine
↗ 2,835
OA
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
Éric Raymond, Laëtitia Dahan, Jean‐Luc Raoul, et al.
·
2011
·
New England Journal of Medicine
↗ 2,529
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
H. Wilke, Kei Muro, Eric Van Cutsem, et al.
·
2014
·
The Lancet Oncology
↗ 2,446
Books
Side Effects of Medical Cancer Therapy
2012
·
Springer
Colorectal Cancer
2006
·
Taylor & Francis Group
Locoregional Tumor Therapy
2014
·
Springer London, Limited